Consistently, western blotting confirmed that FTD stimulated EGFR phosphorylation at threonine (T) 669 and serine (S) 1046/1047, but not at known tyrosine phosphorylation sites (Fig. 4A). The gene discussed is EGFR; the disease is frontotemporal dementia.